Ad
related to: BIIB
Search results
Biogen maintains stock target with Buy rating on acquisition intention By Investing.com
Investing.com· 5 days agoOn Wednesday, Biogen Inc (NASDAQ:BIIB) received confirmation from Stifel that its Buy rating and...
Biogen (BIIB) to Buy HI-Bio to Expand Rare Disease Pipeline
Zacks via Yahoo Finance· 4 days agoBiogen BIIB entered into a definitive agreement to acquire private biotech, HI-Bio, for a $1.15...
BIIB INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Biogen Inc. Investors with...
KTLA-TV Los Angeles· 4 days ago("Biogen Inc." or "the Company") (NASDAQ: BIIB) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal ...
Why Is Biogen (BIIB) Up 7.7% Since Last Earnings Report?
Zacks via Yahoo Finance· 3 days agoA month has gone by since the last earnings report for Biogen Inc. (BIIB). Shares have added about...
Biotech Stock Roundup: BIIB's Acquisition, PTCT, LRMR Gain on Updates & More News
Zacks via Yahoo Finance· 4 days agoRecap of the Week’s Most Important Stories: Updates From Biogen: Biogen BIIB entered into an...
The Biggest Biotechnology Company in Europe
Insider Monkey via Yahoo Finance· 10 hours agoWe’ve recently covered a list of 20 Biggest Publicly-Traded Biotech Companies based on market caps that you can visit here. Biotechnology and Industry...
Biogen shares maintain overweight rating By Investing.com
Investing.com· 5 days agoOn Wednesday, Morgan Stanley (NYSE:MS) maintained its positive stance on Biogen (NASDAQ:BIIB), the...
Why Biogen Inc. (BIIB) is a Top Momentum Stock for the Long-Term
Zacks via Yahoo Finance· 6 days agoThis Score can pinpoint good times to build a position in a stock, using factors like one-week price...
Pomerantz Law Firm Announces the Filing of a Class Action Against Biogen Inc. and Certain Officers -...
KTLA-TV Los Angeles· 5 days agoPomerantz LLP announces that a class action lawsuit has been filed against Biogen Inc. ("Biogen" or the"Company") (NASDAQ: BIIB) and certain officers. The class action, filed ...
Robeco Institutional Asset Management B.V. Sells 180,219 Shares of Biogen Inc. (NASDAQ:BIIB)
ETF DAILY NEWS· 2 days agoRobeco Institutional Asset Management B.V. trimmed its position in Biogen Inc. (NASDAQ:BIIB – Free Report) by 52.7% in the 4th quarter, according to its most recent 13F filing ...
